Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and lowers the price target from $160 to $8.
August 30, 2023 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Underweight rating on Bright Health Gr and significantly lowered the price target from $160 to $8.
The significant reduction in the price target for Bright Health Gr by Morgan Stanley indicates a negative outlook for the company. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100